^
Association details:
Biomarker:No biomarker
Cancer:Prostate Cancer
Drug:goserelin acetate (GnRH agonist) +
nilutamide (Androgen receptor antagonist)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Prostate cancer: PRINCIPLES OF ANDROGEN DEPRIVATION THERAPY...ADT for Regional (N1,M0) Disease…Options for ADT are: LHRH agonist...Goserelin, histrelin, leuprolide, or triptorelin...plus first-generation antiandrogen...Nilutamide, flutamide, or bicalutamide